Virologist Dr. John Dye of the US Army Medical Research Institute of Infectious Diseases gives the government’s latest thinking on COVID-19, natural immunity, successful emerging treatments, and what lies ahead.
This week on Full Measure, beyond the Covid-19 vaccine, what else is emerging to protect American lives? I’ll speak to a top government virologist who gives us the inside scoop on what seems to be promising. We’ve already profiled one
New Covid-19 Treatments; Election Aftermath; and Custer’s Last Stand Read More »
The Centers for Disease Control (CDC) is warning that a highly-contagious United Kingdom “variant” of Covid-19 has been reported in at least ten states. But a top government expert in the coronavirus pandemic recently told me that development is entirely
Top virologist says UK Covid-19 “variant” was expected Read More »
As the coronavirus pandemic rages on, there’s more controversy than clarity when it comes to issues like lockdowns, vaccines, immunity and origin. Dr. John Dye, the lead virologist at the US Army Medical Research Institute of Infectious Diseases answered some
Summary: Virologist Dr. John Dye of the US Army Medical Research Institute of Infectious Diseases gives the government’s latest thinking on COVID-19 vaccines, immunity, asymptomatic spread, and origin.
Dr. John Dye answers your Covid-19 questions (PODCAST) Read More »
Did you know: When the first two Covid-19 vaccines were approved for emergency use they were proven effective for most people, but only anywhere from two weeks to two months? Will you need booster shots soon? What’s an RNA vaccine,
Covid-19 Q-and-A; Impeachment nuts and bolts; and The New Rules War Read More »
Top government virologist Dr. John Dye answers a variety of questions you might want to ask yourself on this week’s episode of Full Measure.
The skinny on all things Covid-19, according to virologist John Dye (PODCAST) Read More »
There’s important coronavirus news. Scientists at Stanford University in California are now beginning a landmark study. They’re using new antibody tests to identify people who already had coronavirus but never knew it because they had no major symptoms. They could
